Michael D. Tarantino

Statistics

Publications

Citations

H-Index

Active since

1991

Affiliations

Bleeding & Clotting Disorders Institute(Current)

Illinois College

Amgen (United States)

Cornell University

Indiana Hemophilia and Thrombosis Center

Michael D. Tarantino is an author at Bleeding & Clotting Disorders Institute specializing in medicine, hematology, and immune-mediated thrombocytopenia.

ORCID

Publications per year

1991–2025

Publications

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 862 citations

Medicine, Hematology, Pharmacology +6

Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccination

Eun‐Ju Lee, Douglas B. Cines, Terry Gernsheimer et al. · American Journal of Hematology · 2021 · 388 citations · Full text

Medicine, Hematology, Infectious Diseases +11

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study

Michael D. Tarantino, James B. Bussel, Victor S. Blanchette et al. · The Lancet · 2016 · 155 citations

Medicine, Hematology, Immunology +9

The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings

Julian Lin, William C. Hanigan, Michael D. Tarantino et al. · Journal of neurosurgery · 2003 · 141 citations

Medicine, Neurosurgery, Surgery +17

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin‐free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A<sup>1</sup>

Michael D. Tarantino, Peter W. Collins, C. R. M. Hay et al. · Haemophilia · 2004 · 139 citations

Medicine, Pharmacokinetics, Pharmacology +14

1–5 of 66